Homeostatic control of immunity by TCR peptide-specific Tregs

Journal of Clinical Investigation

Volumn 114, Issue 9, 2004, Pages 1222-1226

  Kumar, Vipin ^a,b  

^a TORREY PINES INSTITUTE FOR MOLECULAR STUDIES   (United States)

^b TPIMS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; INTERLEUKIN 2 RECEPTOR ALPHA; MYELIN BASIC PROTEIN; T LYMPHOCYTE RECEPTOR; INTERLEUKIN 2 RECEPTOR; LYMPHOCYTE ANTIGEN RECEPTOR; PEPTIDE;

ALLERGIC ENCEPHALOMYELITIS; ANTIGEN RECOGNITION; HOMEOSTASIS; IMMUNE RESPONSE; IMMUNITY; IMMUNOLOGICAL TOLERANCE; IMMUNOREGULATION; INFECTION; INFLAMMATION; MAJOR HISTOCOMPATIBILITY COMPLEX; MULTIPLE SCLEROSIS; NEGATIVE FEEDBACK; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; REVIEW; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION; TISSUE TRANSPLANTATION; ANIMAL; AUTOIMMUNE DISEASE; BIOLOGICAL MODEL; BIOSYNTHESIS; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CHEMISTRY; HUMAN; IMMUNOLOGY; METABOLISM; PATHOLOGY; PHYSIOLOGY;

ANIMALS; AUTOIMMUNE DISEASES; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; HUMANS; MODELS, BIOLOGICAL; PEPTIDES; RECEPTORS, ANTIGEN, T-CELL; RECEPTORS, INTERLEUKIN-2; T-LYMPHOCYTES, REGULATORY;

EID: 85047690619     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI23166     Document Type: Review

References (66)

1. Jerne, N.K. 1984. Idiotypic networks and other preconceived ideas. Immunol. Rev. 79:5-24.
2. Gershon, R.K., and Kondo, K. 1970. Cell interactions in the induction of tolerance: the role of thymic lymphocytes. Immunology. 18:723-737.
3. + cells in the generation of killer activity. J. Exp. Med. 141:1390-1399.
4. Cantor, H., and Gershon, R.K. 1979. Immunological circuits: cellular composition. Fed. Proc. 38:2058-2064.
5. Eardley, D.D., and Gershon, R.K. 1975. Feedback induction of suppressor T-cell activity. J. Exp. Med. 142:524-529.
6. Binz, H., and Wigzell, H. 1976. Specific transplantation tolerance induced by autoimmunization against the individual's own, naturally occurring idiotypic, antigen-binding receptors. J. Exp. Med. 144:1438-1457.
7. BeIIgrau, D., and Wilson, D.B. 1978. Immunological studies of T-cell receptors. I. Specifically induced resistance to graft-versus-host disease in rats mediated by host T-cell immunity to alloreactive parental T cells. J. Exp. Med. 148:103-114.
8. Ben-Nun, A., Wekerle, H., and Cohen, I.R. 1981. Vaccination against autoimmune encephalomyelitis with T-lymphocyte line cells reactive against myelin basic protein. Nature. 292:60-61.
9. Kimura, H., and Wilson, D.B. 1984. Anti-idiotypic cytotoxic T cells in rats with graft-versus-host disease. Nature. 308:463-464.
10. Sun, D., Qin, Y., Chluba, J., Epplen, J.T., and Wekerle, H. 1988. Suppression of experimentally induced autoimmune encephalomyelitis by cytolytic T-T cell interactions. Nature. 332:843-845.
11. Zhang, J., Medaer, R., Stinissen, P., Hafler, D., and Raus, J. 1993. MHC-restricted depletion of human myelin basic protein-reactive T cells by T cell vaccination. Science. 261:1451-1454.
12. Koh, D.-R., et al. 1992. Less mortality but more relapses in experimental allergic encephalomyeltis in CD8-/- mice. Science. 256:1210-1213.
13. Jiang, H., Zhang, S.I., and Pernis, B. 1992. Role of CD8+ T cells in murine experimental allergic encephalomyelitis. Science. 256:1213-1215.
14. Lohse, A.W., et al. 1993. Induction of the anti-ergotypic response. Int. Immunol. 5:533-539.
15. Kumar, V., and Sercarz, E. 1993. T cell regulatory circuitry: antigen-specific and TCR-idiopeptide-specific T cell interactions in EAE. Int. Rev. Immunol. 9:287-297
16. Madakamutil, L.T., Maricic, I., Sercarz, E., and Kumar, V. 2003. Regulatory T cells control autoimmunity in vivo by inducing apoptotic depletion of activated pathogenic lymphocytes. J. Immunol. 170:2985-2992.
17. Kibler, R.F., et al. 1977. Immune response of Lewis rats to peptide C1 (residues 68-88) of guinea pig and rat myelin basic proteins. J. Exp. Med. 146:1323-1331.
18. Zamvil, S.S., et al. 1986. T-cell epitope of the autoantigen myelin basic protein chat induces encephalomyelitis. Nature. 324:258-260.
19. Urban, J.L., et al. 1988. Restricted use of T cell receptor V genes in murine autoimmune encephalomyelitis raises possibilities for antibody therapy. Cell. 54:577-592.
20. Acha-Orbea, H., et al. 1988. Limited heterogeneity of T cell receptors from lymphocytes mediating autoimmune encephalomyelitis allows specific immune intervention. Cell. 54:263-273.
21. Kumar, V., Kono, D.H., Urban, J.L., and Hood, L. 1989. The T-cell receptor repertoire and autoimmune diseases. Annu. Rev. Immunol. 7:657-682.
22. Burns, F.R., et al. 1989. Both rat and mouse T cell receptors specific for the encephalitogenic determinant of myelin basic protein use similar V and V chain genes. J. Exp. Med. 169:27-39.
23. Howell, M.D., et al. 1989. Vaccination against experimental allergic encephalomyelitis with T cell receptor peptides. Science. 246:668-670.
24. Vandenbark, A.A., Hashim, G., and Offner, H. 1989. Immunization with a synthetic T-cell receptor V-region peptide protects against experimental autoimmune encephalomyelitis. Nature. 341:541-544.
25. Karpus, W.J., Gould, K.E., and Swanborg, R.H. 1992. CD4+ suppressor cells of autoimmune encephalomyelitis respond to T cell receptor-associated determinants on effector cells by interleukin-4 secretion. Eur. J. Immunol. 22:1757-1763.
26. + T cells in recovery from antigen-induced autoimmune disease. J. Exp. Med. 178:909-916.
27. Kumar, V., Tabibiazar, R., Geysen, H.M., and Sercarz, E. 1995. Immunodominant framework region 3 peptide from TCR V beta 8.2 chain controls murine experimental autoimmune encephalomyelitis. J. Immunol. 154:1941-1950.
28. Kumar, V., Stellrecht, K., and Sercarz, E. 1996. Inactivation of T cell receptor peptide-specific CD4 regulatory T cells induces chronic experimental autoimmune encephalomyelitis (EAE). J. Exp. Med. 184:1609-1617.
29. Kumar, V., Aziz, F., Sercarz, E., and Miller, A. 1997. Regulatory T cells specific for the same framework 3 region of the Vbeta8.2 chain are involved in the control of collagen II-induced arthritis and experimental autoimmune encephalomyelitis. J. Exp. Med. 185:1725-1733.
30. Vainiene, M., et al. 1996. Neonatal injection of Lewis rats with recombinant V beta 8.2 induces T cell but not B cell tolerance and increased severity of experimental autoimmune encephalomyelitis. J. Neurosci. Res. 45:475-486.
31. MacNeil, D., Fraga, E., and Singh, B. 1993. Characterization of murine T cell responses to peptides of the variable region of self T cell receptor beta-chains. J. Immunol. 151:4045-4054.
32. Jesson, M.I., et al. 1998. The immune response to soluble D10 TCR: analysis of antibody and T cell responses. Int. Immunol. 10:27-35.
33. Falcioni, F., et al. 1995. Self tolerance to T cell receptor V beta sequences. J. Exp. Med. 182:249-254.
34. Saruhan-Direskeneli, G., et al. 1993. Human T cell autoimmunity against myelin basic protein: CD4+ cells recognizing epitopes of the T cell receptor beta chain from a myelin basic protein-specific T cell clone. Eur. J. Immunol. 23:530-536.
35. Zang, Y.C., Hong, J., Rivera, V.M., Killian, J., and Zhang, J.Z. 2000. Preferential recognition of TCR hypervariable regions by human anti-idiotypic T cells induced by T cell vaccination. J. Immunol. 164:4011-4017.
36. Vandenbark, A.A., Hashim, G.A., and Offner, H. 1996. T cell receptor peptides in treatment of autoimmune disease: rationale and potential. J. Neurosci. Res. 43:391-402.
37. Kumar, V., and Sercarz, E. 1996. Dysregulation of potentially pathogenic self reactivity is crucial for the manifestation of clinical autoimmunity. J. Neurosci. Res. 45:334-339.
38. Kumar, V., et al. 1997. Recombinant T cell receptor molecules can prevent and reverse experimental autoimmune encephalomyelitis: dose effects and involvement of both CD4 and CD8 T cells. J. Immunol. 159:5150-5156.
39. Kumar, V. 1998. TCR peptide-reactive T cells and peripheral tolerance to myelin basic protein. Res. Immunol. 149:827-834; discussion 852-854, 855-860.
40. Kumar, V., and Sercarz, E. 2001. An integrative model of regulation centered on recognition of TCR peptide/MHC complexes. Immunol. Rev. 182:113-121.
41. Vandenbark, A.A., et al. 1996. Treatment of multiple sclerosis with T-cell receptor peptides: results of a double-blind pilot trial. Nat. Med. 2:1109-1115.
42. Jiang, H., et al. 1995. Murine CD8+ T cells that specifically delete autologous CD4+ T cells expressing V beta 8 TCR: a role of the Qa-1 molecule. Immunity. 2:185-194.
43. Jiang, H., et al. 1998. T cell vaccination induces T cell receptor Vbeta-specific Qa-1-restricted regulatory CD8(+) T cells. Proc. Natl. Acad. Sci. U. S. A. 95:4533-4537.
44. Jiang, H., and Chess, L. 2000. The specific regulation of immune responses by CD8+ T cells restricted by the MHC class Ib molecule, Qa-1. Annu. Rev. Immunol. 18:185-216.
45. Kuhrober, A., Schirmbeck, R., and Reimann, J. 1994. Vaccination with T cell receptor peptides primes anti-receptor cytotoxic T lymphocytes (CTL) and anergizes T cells specifically recognized by these CTL. Eur. J. Immunol. 24:1172-1180.
46. Gapin, L., Cheroutre, H., and Kronenberg, M. 1999. Cutting edge: TCR alpha beta+ CD8 alpha alpha+ T cells are found in intestinal intraepithelial lymphocytes of mice that lack classical MHC class I molecules. J. Immunol. 163:4100-4104.
47. Offner, H., Hashim, G.A., and Vandenbark, A.A. 1991. T cell receptor peptide therapy triggers auto-regulation of experimental encephalomyelitis. Science. 251:430-432.
48. Mueller, D.L., Jenkins, M.K., and Schwartz, R.H. 1989. Clonal expansion versus functional clonal inactivation: a costimulatory signalling pathway determines the outcome of T cell antigen receptor occupancy. Annu. Rev. Immunol. 7:445-480.
49. Kappler, J.W., Roehm, N., and Marrack, P. 1987. T cell tolerance by clonal elimination in the thymus. Cell. 49:273-280.
50. Coffman, R.L., Varkila, K., Scott, P., and Chatelain, R. 1991. Role of cycokines in the differentiation of CD4+ T-cell subsets in vivo. Immunol. Rev. 123:189-207
51. Gaur, A., Ruberti, G., Haspel, R., Mayer, J.P., and Fathman, G.G. 1993. Requirement for CD8+ cells in T cell receptor peptide-induced clonal unresponsiveness. Science. 259:91-94.
52. Jiang, H., et al. 2003. Regulatory CD8+ T cells fine-tune the myelin basic protein-reactive T cell receptor V beta repertoire during experimental autoimmune encephalomyelitis. Proc. Natl. Acad. Sci. U. S. A. 100:8378-8383.
53. Jiang, H., Braunstein, N.S., Yu, B., Winchester, R., and Chess, L. 2001. CD8+ T cells control the TH phenotype of MBP-reactive CD4+ T cells in EAE mice. Proc. Natl. Acad. Sci. U. S. A. 98:6301-6306.
54. Kumar, V., and Sercarz, E. 1998. Induction or protection from experimental autoimmune encephalomyelitis depends on the cytokine secretion profile of TCR peptide-specific regulatory CD4 T cells. J. Immunol. 161:6585-6591.
55. Braciak, T.A., et al. 2003. Protection against experimental autoimmune encephalomyelitis generated by a recombinant adenovirus vector expressing the V beta 8.2 TCR is disrupted by coadministration with vectors expressing either IL-4 or -10. J. Immunol. 170:765-774.
56. Waisman, A., et al. 1996. Suppressive vaccination with DNA encoding a variable region gene of the T-cell receptor prevents autoimmune encephalomyelitis and activates Th2 immunity. Nat. Med. 2:899-905.
57. Kumar, V., et al. 2001. Induction of a type 1 regulatory CD4 T cell response following V(beta)8.2 DNA vaccination results in immune deviation and protection from experimental autoimmune encephalomyelitis. Int. Immunol. 13:835-841.
58. Lehmann, P.V., Forsthuber, T., Miller, A., and Sercarz, E.E. 1992. Spreading of T-cell autoimmunity to cryptic determinants of an autoantigen. Nature. 358:155-157.
59. Brocke, S., et al. 1996. Treatment of experimental encephalomyelitis with a peptide analogue of myelin basic protein. Nature. 379:343-346.
60. Murali-Krishna, K., et al. 1998. Counting antigen-specific CD8 T cells: a reevaluation of bystander activation during viral infection. Immunity. 8:177-187.
61. Gold, D.P., et al. 1997. Results of a phase I clinical trial of a T-cell receptor vaccine in patients with multiple sclerosis. II. Comparative analysis of TCR utilization in CSF T-cell populations before and after vaccination with a TCRV beta 6 CDR2 peptide. J. Neuroimmunol. 76:29-38.
62. Zhang, I., and Raus, J. 1996. T cell vaccination in multiple sclerosis. Mult. Scler. 1:353-356.
63. Kumar, V., Sercarz, E., Zhang, J., and Cohen, I. 2001. T-cell vaccination: from basics to the clinic. Trends Immunol. 22:539-540.
64. Matsumoto, Y., Jee, Y., and Sugisaki, M. 2000. Successful TCR-based immunotherapy for autoimmune myocarditis with DNA vaccines after rapid identification of pathogenic TCR. J. Immunol. 164:2248-2254.
65. Kumar, V., and Sercarz, E. 1996. Genetic vaccination: the advantages of going naked. Nat. Med. 2:857-859.
66. Chunduru, S.K., Sutherland, R.M., Stewart, G.A., Doms, R.W., and Paterson, Y. 1996. Exploitation of the Vbeta8.2 T cell receptor in protection against experimental autoimmune encephalomyelitis using a live vaccinia virus vector. J. Immunol. 156:4940-4945.